inclisiran

Product

Twice-yearly injectable siRNA therapy targeting PCSK9 for cholesterol reduction

2 stories

New Cholesterol Guidelines Released With Major Treatment Updates

New Cholesterol Guidelines Recommend Lower Targets and Earlier Treatment